{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:11:34Z","timestamp":1787314294876,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.cmi.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T02:02:30Z","timestamp":1423879350000},"page":"604.e1-604.e9","source":"Crossref","is-referenced-by-count":64,"title":["Current preventive strategies and management of Epstein\u2013Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey"],"prefix":"10.1016","volume":"21","author":[{"given":"R.","family":"San-Juan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.H.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"L\u00f3pez-Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Comoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a04","key":"10.1016\/j.cmi.2015.02.002_bib1","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-6143.2009.02898.x","article-title":"Epstein\u2013Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients","volume":"9","author":"Allen","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11912-010-0132-1","article-title":"Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy","volume":"12","author":"Evens","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.cmi.2015.02.002_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cmi.2015.02.002_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cmi.2015.02.002_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/TP.0b013e3181b9692d","article-title":"Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma","volume":"88","author":"Opelz","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2011.03499.x","article-title":"Epstein\u2013Barr virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy","volume":"11","author":"Nourse","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2141.2011.08855.x","article-title":"Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein\u2013Barr virus-associated lymphoproliferative disease following stem cell transplantation","volume":"155","author":"Worth","year":"2011","journal-title":"Br J Haematol"},{"issue":"Suppl.\u00a07","key":"10.1016\/j.cmi.2015.02.002_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1469-0691.12534","article-title":"Epstein\u2013Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients","volume":"20","author":"San-Juan","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2015.02.002_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcv.2010.12.002","article-title":"Multicenter comparative study of Epstein\u2013Barr virus DNA quantification for virological monitoring in transplanted patients","volume":"50","author":"Abbate","year":"2011","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2015.02.002_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/CMR.00006-09","article-title":"Using Epstein\u2013Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder","volume":"23","author":"Gulley","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2015.02.002_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-6143.2008.02514.x","article-title":"Interlaboratory comparison of Epstein\u2013Barr virus viral load assays","volume":"9","author":"Preiksaitis","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib14","series-title":"Collaborative study to evaluate the proposed 1st WHO International Standard for Epstein\u2013Barr Virus (EBV) for nucleic acid amplification technology (NAT)-based assays","author":"Fryer","year":"2011"},{"key":"10.1016\/j.cmi.2015.02.002_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the french registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib16","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/ndt\/gfr769","article-title":"Impact of Epstein\u2013Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients","volume":"27","author":"Sampaio","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2009-02-202507","article-title":"Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation","volume":"114","author":"van Leeuwen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2015.02.002_bib18","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1111\/j.1600-6143.2011.03704.x","article-title":"Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients","volume":"11","author":"Fernberg","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00007890-200210270-00008","article-title":"Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients","volume":"74","author":"Duvoux","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.tp.0000173793.03228.bd","article-title":"HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical","volume":"80","author":"Bakker","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(07)70040-2","article-title":"Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-hodgkin lymphoma: a multicentre retrospective analysis","volume":"8","author":"Opelz","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cmi.2015.02.002_bib22","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1600-6143.2006.01394.x","article-title":"CMV-IVIG for prevention of Epstein\u2013Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients","volume":"6","author":"Green","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/JCM.39.2.564-569.2001","article-title":"Normalized quantification by real-time PCR of Epstein\u2013Barr virus load in patients at risk for posttransplant lymphoproliferative disorders","volume":"39","author":"Jabs","year":"2001","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2015.02.002_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2010.03.016","article-title":"EBV viral load detection in clinical virology","volume":"48","author":"Gartner","year":"2010","journal-title":"J\u00a0Clin Virol"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.cmi.2015.02.002_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/ajt.12104","article-title":"Epstein\u2013Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation","volume":"13","author":"Allen","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.cmi.2015.02.002_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein\u2013Barr virus infection and posttransplant lymphoproliferative disorder","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00007890-200109270-00006","article-title":"Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein\u2013Barr viral load by using real-time quantitative polymerase chain reaction","volume":"72","author":"Wagner","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/00007890-200209150-00012","article-title":"Longitudinal analysis of Epstein\u2013Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction","volume":"74","author":"Wagner","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1473-3099(07)70159-7","article-title":"Viral dynamics in transplant patients: implications for disease","volume":"7","author":"Funk","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2015.02.002_bib30","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/JCM.01676-14","article-title":"Commutability of the Epstein\u2013Barr virus WHO International Standard across two quantitative PCR methods","volume":"52","author":"Abeynayake","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2015.02.002_bib31","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1600-6143.2005.01002.x","article-title":"Quantitative EBV viral loads and immunosuppression alterations can decrease ptld incidence in pediatric liver transplant recipients","volume":"5","author":"Lee","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.tp.0000252784.60159.96","article-title":"Epstein\u2013Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression","volume":"83","author":"Bakker","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/00007890-199812270-00006","article-title":"Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients","volume":"66","author":"McDiarmid","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ajt.12640","article-title":"Adapted treatment of Epstein\u2013Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation","volume":"14","author":"Choquet","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib35","first-page":"1600","article-title":"Monitoring infection with Epstein\u2013Barr virus among seromismatch adult renal transplant recipients","volume":"14","author":"Martin","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2015.02.002_bib36","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1053\/j.ajkd.2006.01.029","article-title":"Sirolimus-induced remission of posttransplantation lymphoproliferative disorder","volume":"47","author":"Cullis","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2015.02.002_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/TP.0b013e31823ae7db","article-title":"Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients","volume":"93","author":"Sampaio","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2015.02.002_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/lt.21498","article-title":"Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein\u2013Barr virus","volume":"14","author":"Hierro","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cmi.2015.02.002_bib39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.transproceed.2009.02.053","article-title":"Impact of valganciclovir on Epstein\u2013Barr virus polymerase chain reaction in pediatric liver transplantation: preliminary report","volume":"41","author":"Venturi","year":"2009","journal-title":"Transplant Proc"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15002888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15002888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T02:50:30Z","timestamp":1537843830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15002888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1198743X15002888"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.02.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}